【発明の名称】プロゲステロンレセプタ結合剤として用いるための置換2-アリールイミノ複素環類およびそれを含有する組成物

Japanese Patent JP2002534517

A

This invention relates to 2-arylimino heterocycles, including 2-arylimino-1, 3-thiazolidines, 2-arylimino-2, 3, 4, 5-tetrahydro-1, 3-thiazines, 2-arylimino-1, 3-thiazolidin-4-ones, 2-arylimino-1, 3-thiazolidin-5-ones, and 2-arylimino-1, 3-oxazolidines, and their use in modulating progesterone receptor mediated processes, and pharmaceutical compositions for use in such therapies.

Brian Earle, Dixon
Bagi, Sed Em
Brennan, Katherine Earl
Brittelli, David Earl
Baroque, William H
Chiang, Jinshiang
Corbye, William El
Robert Dally
Ji Young Sung, Jeffrey S
Klunder, Harold See Yi
Lathrop, William F
Riu, paying
Maceor, Carroll Ann
Redman, Anico M
Scott, William J.A.
Woolburns, Claus
Wollanine, Donald J. Ray

JP2000593599A

October 15, 2002

December 14, 1999

Click for automatic bibliography generation  

BAYER CORPORATION

A61K31/4164; A61K31/421; A61K31/423; A61K31/425; A61K31/426; A61K31/427; A61K31/428; A61K31/429; A61K31/437; A61K31/54; A61K31/55; A61P5/00; A61P5/24; A61P9/00; A61P9/10; A61P13/00; A61P15/00; A61P15/04; A61P15/08; A61P15/10; A61P15/16; A61P15/18; A61P17/00; A61P19/00; A61P19/10; A61P25/00; A61P25/24; A61P25/28; A61P35/00; A61P41/00; C07D263/28; C07D263/52; C07D233/42; C07D277/18; C07D277/20; C07D277/42; C07D277/54; C07D277/60; C07D279/06; C07D281/02; C07D417/06; C07D417/12; C07D513/04; C07D513/10; A61K; A61P; C07D; (IPC1-7): C07D277/18; A61K31/4164; A61K31/421; A61K31/425; A61K31/427; A61K31/428; A61K31/429; A61K31/437; A61K31/54; A61P5/00; A61P5/24; A61P9/10; A61P13/00; A61P15/00; A61P15/04; A61P15/08; A61P15/10; A61P15/16; A61P17/00; A61P19/00; A61P19/10; A61P25/00; A61P25/24; A61P25/28; A61P35/00; A61P41/00; C07D233/42; C07D263/28; C07D277/42; C07D277/60; C07D279/06; C07D417/06; C07D417/12; C07D513/04; C07D513/10

Heiyoshi Odashima

Previous Patent: JP2002534516

Next Patent: エンドセリン受容体アンタゴニストとしての４−（ヘテロシクリルスルホ�...